Am J Physiol Cell Physiol AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 290: C1532-C1542, 2006. First published January 4, 2006; doi:10.1152/ajpcell.00478.2005
0363-6143/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/C1532    most recent
00478.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmed, N.
Right arrow Articles by Auersperg, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, N.
Right arrow Articles by Auersperg, N.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium

Nuzhat Ahmed,1,2 Sarah Maines-Bandiera,3 Michael A. Quinn,1 Waldemar G. Unger,3 Shoukat Dedhar,4 and Nelly Auersperg3

1Gynaecological Cancer Research Centre, Royal Women's Hospital, Carlton, and Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne; 2Translational Proteomics, Baker Heart Research Institute, Melbourne, Victoria, Australia; 3Department of Obstetrics and Gynaecology and 4British Columbia Cancer Agency, The Prostate Centre at Vancouver Hospital, and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada

Submitted 26 September 2005 ; accepted in final form 17 November 2005

The ovarian surface epithelium (OSE) is the precursor of common epithelial ovarian carcinomas. In the present study, we examined the molecular mechanisms and possible physiological basis for the propensity of OSE cells to undergo epithelio-mesenchymal transition (EMT) in response to environmental influences. We hypothesized that EMT may be a homeostatic mechanism that permits displaced OSE to assume a stromal phenotype within the ovarian cortex. We report that EGF in conjunction with hydrocortisone is the EMT-inducing factor of OSE as shown by changes to a fibroblast-like morphology and growth pattern. EGF increased cell motility, enhanced the activities of secreted pro-matrix metalloproteinase (MMP)-2 and -9, and enhanced expression and activation of Erk and integrin-linked kinase (ILK). Increased ILK expression correlated with the activation of PKB/Akt, the phosphorylation of GSK-3beta, and the increased expression of cyclin E and cdk2 kinase. EGF withdrawal resulted in a more epithelial morphology and reversal of the EGF-induced activation of signaling pathways and pro-MMP activity. In contrast, treatment of EGF-treated cells with specific inhibitors of phosphatidylinositol 3-kinase, Mek, or ILK inhibited the inhibitor-specific pathways. The inhibitors caused suppression of EGF-induced migration and pro-MMP-2/-9 activities but did not lead to any change in EGF-induced mesenchymal morphology. ILK small interfering RNA inhibited Akt phosphorylation and reduced pro-MMP-2/-9 activities but had no effect on Erk activation or cell morphology. These results indicate that the EGF-induced morphological and functional changes in OSE cells are controlled by distinct signaling mechanisms working in concert. EMT of OSE cells displaced by ovulation likely permits their survival and integration with a fibroblast-like identity within the stroma. Failure to do so may lead to the formation of epithelium-derived inclusion cysts, which are known preferential sites of malignant transformation.

epidermal growth factor; migration; invasion



Address for reprint requests and other correspondence: N. Ahmed, Gynaecological Cancer Research Centre, Royal Women's Hospital, 132 Grattan St., Carlton, Victoria 3053, Australia (e-mail: nuzhata{at}unimelb.edu.au)




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
H. Yagi, F. Yotsumoto, and S. Miyamoto
Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition
Mol. Cancer Ther., October 1, 2008; 7(10): 3441 - 3451.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. K. Nath, R. M. Brown, M. Michaud, M. R. Sierra-Honigmann, M. Snyder, and J. A. Madri
Leptin affects endocardial cushion formation by modulating EMT and migration via Akt signaling cascades
J. Cell Biol., April 21, 2008; 181(2): 367 - 380.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
O. Rosso, T. Piazza, I. Bongarzone, A. Rossello, D. Mezzanzanica, S. Canevari, A. M. Orengo, A. Puppo, S. Ferrini, and M. Fabbi
The ALCAM Shedding by the Metalloprotease ADAM17/TACE Is Involved in Motility of Ovarian Carcinoma Cells
Mol. Cancer Res., December 1, 2007; 5(12): 1246 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. Mimeault and S. K. Batra
Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies
Ann. Onc., October 1, 2007; 18(10): 1605 - 1619.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.